Methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate, 95.0%, 25g

2,5-Dichloro-3-methylpyridine, 95.0%, 25g

(S)-Methyl 2-amino-3-(tert-butoxycarbonylamino)-3-methylbutanoate, 95.0%, 5g

TAZEMETOSTAT, 98%, 250mg

Fmoc-Ser(tBu)-OH, 98%, 100g

Silica gel 2500, 10 g

(2E)-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(R)-4-Amino-4-oxo-2-(tritylamino)butanoic acid, 95.0%, 1g

ETHANOL,2-[BIS(2-CHLOROETHYL)AMINO]-,HCL, 95.0%, 1g

1-[(3-bromophenyl)methyl]-3-nitro-1H-pyrazole, 95.0%, 1g

Sample vials ROTILABO® with snap-on ring ND11, Brown glass, with labelling space, 1.5 ml, 100 Piece(s)

(+)-Borneol>95.0%(GC)1g

(3-(3-Hydroxypropyl)phenyl)boronic acid, 95.0%, 1g